HIV

News

Eyes on GSK as Pfizer prepares to sell consumer division

GlaxoSmithKline saw its share price fall 6% yesterday after releasing underwhelming figures in Q3, and leaving investors uncertain about its future dividend payments.

News

Study backs HIV testing in GP surgeries in high-risk areas

GP surgeries should test new patients for HIV in areas of high prevalence as it is cost-effective, according to a new study.

News

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV...

Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV.

News

HIV vaccine shows ‘encouraging’ early results

Janssen has unveiled what it calls ‘encouraging’ early results of its vaccine to prevent infection by HIV.

News

Gilead's new blockbuster HIV combination nears filing

Pharma looks to file bictegravir and F/TAF later this year.

News

Call for inquiry into NHS contaminated blood scandal

Former health secretary says scandal was "criminal" cover-up.

Eyes on GSK as Pfizer prepares to sell consumer division

Study backs HIV testing in GP surgeries in high-risk areas

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV...

HIV vaccine shows ‘encouraging’ early results

Gilead's new blockbuster HIV combination nears filing

Call for inquiry into NHS contaminated blood scandal

As Ebola deaths climb, search begins for vaccine

Discover a new era of healthcare panel engagement: Grounded ...

HIV

Editor's Picks